ArticleJournal of thoracic disease2026
Prognostic stratification of T1 lung adenocarcinoma with micropapillary or solid patterns: a cohort study.
Article in Journal of thoracic disease, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Surgical approach and prognosis in patients with ≤2 cm grade 3 lung adenocarcinoma: a multivariable analysis of disease-free and overall survival.Journal of thoracic disease · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: The impact of micropapillary and/or solid (MP/S) patterns on prognostic stratification within T1 subcategories (T1a-b and T1c) is uncertain. We aimed to evaluate the prognostic stratification of combined MP/S status and tumor size, and to compare the outcomes of micropapillary and/or solid positive (MP/S Methods: We examined 586 patients who underwent curative resection for stage I invasive lung adenocarcinoma from January 2018 to December 2019. We compared survival outcomes among T1 subcategories classified by MP/S. The primary endpoints were overall survival (OS) and recurrence-free survival (RFS). Kaplan-Meier method was used to estimate survival, and log-rank tests were used to compare the two groups. Results: Among 586 patients, 184 (31.4%) were MP/S Conclusions: MP/S patterns indicate higher-risk subgroups within T1 lung adenocarcinoma. Incorporating MP/S status into postoperative risk evaluation may enhance prognostic accuracy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.